Clinical trial
Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer
NCT01333033 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- April 1, 2023
- Enrollment
- 257 (actual)
- Sites
- 68
Conditions
As the registry lists them; a condition with its own page is linked.
adenocarcinoma of the gastroesophageal junction, esophageal cancer